Sara Haghighi

1.2k total citations
35 papers, 944 citations indexed

About

Sara Haghighi is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Sara Haghighi has authored 35 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 12 papers in Molecular Biology and 9 papers in Neurology. Recurrent topics in Sara Haghighi's work include Multiple Sclerosis Research Studies (20 papers), Polyomavirus and related diseases (5 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Sara Haghighi is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Polyomavirus and related diseases (5 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Sara Haghighi collaborates with scholars based in Sweden, Italy and United States. Sara Haghighi's co-authors include Jan Lycke, Lars Rosengren, Clas Malmeström, Oluf Andersen, Staffan Nilsson, Markus Axelsson, Kaj Blennow, Henrik Zetterberg, Bengt Åndersson and Niklas Mattsson and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Sara Haghighi

33 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Haghighi Sweden 15 497 315 267 155 133 35 944
Kazumasa Okada Japan 17 364 0.7× 186 0.6× 485 1.8× 156 1.0× 80 0.6× 61 1.1k
Stefan Gingele Germany 19 527 1.1× 352 1.1× 255 1.0× 241 1.6× 136 1.0× 59 1.3k
Liat Hayardeny Israel 20 467 0.9× 319 1.0× 169 0.6× 413 2.7× 90 0.7× 35 1.2k
Rita Cittadella Italy 18 233 0.5× 274 0.9× 189 0.7× 74 0.5× 55 0.4× 36 1.0k
Stefan Jung Germany 19 332 0.7× 219 0.7× 414 1.6× 376 2.4× 145 1.1× 32 1.3k
Erik Ellwardt Germany 11 274 0.6× 150 0.5× 144 0.5× 180 1.2× 93 0.7× 23 674
Hideki Houzen Japan 14 317 0.6× 234 0.7× 253 0.9× 63 0.4× 34 0.3× 41 788
Jens Ingwersen Germany 14 261 0.5× 236 0.7× 103 0.4× 294 1.9× 80 0.6× 22 817
Marleen J.A. Koel‐Simmelink Netherlands 17 212 0.4× 313 1.0× 260 1.0× 43 0.3× 55 0.4× 32 821
Courtney E. Batt United States 6 271 0.5× 249 0.8× 97 0.4× 111 0.7× 27 0.2× 10 829

Countries citing papers authored by Sara Haghighi

Since Specialization
Citations

This map shows the geographic impact of Sara Haghighi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Haghighi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Haghighi more than expected).

Fields of papers citing papers by Sara Haghighi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Haghighi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Haghighi. The network helps show where Sara Haghighi may publish in the future.

Co-authorship network of co-authors of Sara Haghighi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Haghighi. A scholar is included among the top collaborators of Sara Haghighi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Haghighi. Sara Haghighi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haghighi, Sara, et al.. (2025). Neurotoxic effects of rotenone and deltamethrin prolonged exposure on adult zebrafish. Scientific Reports. 15(1). 27126–27126.
2.
Kiffin, Roberta, et al.. (2022). Impact of CYBA genotypes on severity and progression of multiple sclerosis. European Journal of Neurology. 29(5). 1457–1464. 3 indexed citations
3.
Frederiksen, Jette Lautrup, Helle Hvilsted Nielsen, Øivind Torkildsen, et al.. (2022). Real-world study of relapsing-remitting multiple sclerosis patients treated with Teriflunomide in Nordic countries: Quality-Of-Life, efficacy, safety and adherence outcomes. Multiple Sclerosis and Related Disorders. 63. 103892–103892. 3 indexed citations
4.
Haghighi, Sara, et al.. (2015). Полиморфный вариант MnSOD A16V и риск развития диабетической ретинопатии. Молекулярная биология. 49(1). 114–118. 4 indexed citations
5.
Constantinescu, Radu, Marie K.L. Nilsson, Maria Carlsson, et al.. (2014). Tolerability and efficacy of the monoaminergic stabilizer (−)-OSU6162 (PNU-96391A) in Huntington’s disease: a double-blind cross-over study. Acta Neuropsychiatrica. 26(5). 298–306. 22 indexed citations
6.
Haghighi, Sara, Annika Lekman, Staffan Nilsson, Maria Blomqvist, & Oluf Andersen. (2013). Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients. Journal of the Neurological Sciences. 326(1-2). 35–39. 16 indexed citations
7.
Haghighi, Sara, et al.. (2011). Protective effects of vitamin E on cyclosporine A-induced toxicity in rat testis.. Koomesh Journal. 12(4). 1 indexed citations
8.
Haghighi, Sara, Annika Lekman, Staffan Nilsson, Maria Blomqvist, & Oluf Andersen. (2011). Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis. Acta Neurologica Scandinavica. 125(1). 64–70. 23 indexed citations
9.
Axelsson, Markus, Clas Malmeström, Staffan Nilsson, et al.. (2010). Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis. Journal of Neurology. 258(5). 882–888. 156 indexed citations
10.
Malmeström, Clas, Jan Lycke, Sara Haghighi, et al.. (2008). Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF. Journal of Neuroimmunology. 196(1-2). 159–165. 59 indexed citations
11.
Mattsson, Niklas, Ulla Rüetschi, Vladimir N. Podust, et al.. (2007). Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis. Journal of Neurochemistry. 103(5). 1932–1939. 27 indexed citations
12.
Haghighi, Sara, Anne‐Marie Landtblom, Staffan Nilsson, et al.. (2007). Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis. Multiple Sclerosis Journal. 13(4). 441–445. 6 indexed citations
13.
Mattsson, Niklas, Sara Haghighi, Oluf Andersen, et al.. (2006). Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients. Neuroscience Letters. 414(3). 233–236. 34 indexed citations
14.
Hansson, Sara, Anja Hviid Simonsen, Henrik Zetterberg, et al.. (2006). Cystatin C in cerebrospinal fluid and multiple sclerosis. Annals of Neurology. 62(2). 193–196. 30 indexed citations
15.
Malmeström, Clas, Bengt Åndersson, Sara Haghighi, & Jan Lycke. (2006). IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: Implications for their possible immunopathogenic roles. Journal of Neuroimmunology. 175(1-2). 176–182. 52 indexed citations
16.
Rezvanian, Hassan, et al.. (2005). The effect of folic acid and levothyroxine combination therapy on serum homocysteine levels of hypothyroid patients. Majallah-i ghudad-i darūn/rīz va mitābulīsm-i Īrān./Majallah-i ghudad-i darūn/rīz va mitābulīsm-i Īrān.. 7(4). 315–319. 1 indexed citations
17.
Malmeström, Clas, Sara Haghighi, Lars Rosengren, Oluf Andersen, & Jan Lycke. (2003). Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS. Neurology. 61(12). 1720–1725. 251 indexed citations
18.
Haghighi, Sara, Oluf Andersen, Anders Odén, & Lars Rosengren. (2003). Cerebrospinal fluid markers in MS patients and their healthy siblings. Acta Neurologica Scandinavica. 109(2). 97–99. 33 indexed citations
19.
Haghighi, Sara, Lars Frisén, Anders Odén, & Oluf Andersen. (2003). Multiple sclerosis siblings with cerebrospinal fluid immunopathy but without any indication of neuronal damage. Acta Neurologica Scandinavica. 108(5). 319–322. 2 indexed citations
20.
Haghighi, Sara, Oluf Andersen, Lars Rosengren, et al.. (2000). Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls. Journal of Neurology. 247(8). 616–622. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazumasa Okada Breakdown of academic impact, for papers by Stefan Gingele Breakdown of academic impact, for papers by Liat Hayardeny Breakdown of academic impact, for papers by Rita Cittadella Breakdown of academic impact, for papers by Stefan Jung Breakdown of academic impact, for papers by Erik Ellwardt Breakdown of academic impact, for papers by Hideki Houzen Breakdown of academic impact, for papers by Jens Ingwersen Breakdown of academic impact, for papers by Marleen J.A. Koel‐Simmelink Breakdown of academic impact, for papers by Courtney E. Batt
Rankless by CCL
2026